Minimize Uncertainty – Make Informed Decisions – Succeed

Endocrinology

Endocrinology Today—January 27, 2026

January 27, 2026BioPharma and Tech News,T2DPCOS,type 2 diabetes,Medtronic,GLP-1 Receptor Agonists,Denosumab,DPP-4 inhibitors,Endocrinology News,prediabetes,Polycystic ovary syndrome

This weekly update in Endocrinology covers regulatory actions, clinical…

by LucidQuest

Obesity Weekly News

Obesity Today—January 27, 2026

January 27, 2026wegovy,semaglutide,roche,BioPharma and Tech News,type 2 diabetes,Ascletis,GLP-1 receptor agonist,Obesity News,Metabolic syndromeCorxel,Chugai

This week's Obesity update highlights late-stage clinical advancement, major…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Fortitude Biomedicines launch with $13M seed

January 27, 2026Oncology,clinical trials,reimbursement,Autoimmune Disease,biopharma,Lucid Diligence Brief,payer access,diligence,venture funding,ADCsmolecular glues

Lucid Diligence Brief: Fortitude Biomedicines launch with $13M seed…

by Timos Papagatsias

Hematology

Hematology Video Recap—January 26, 2026

January 26, 2026Diffuse large B-cell lymphoma,Genmab,FDA,epcoritamab,abbvie,Cadrenal,takeda,Opna Bio,Multiple Myeloma,Heparin-induced thrombocytopenia,immunoglobulin,EPKINLY,primary immunodeficiency,Zavabresib,BioPharma and Tech News,GAMMAGARD LIQUID ERC,Daratumumab,Darzalex,myelofibrosis,Ipsen,Acute Myeloid LeukemiaHematology News,PharmaEssentia

This biweekly hematology video covers regulatory actions, clinical progress in…

by LucidQuest

Hematology

Hematology Today—January 26, 2026

January 26, 2026Multiple Myeloma,primary immunodeficiency,BioPharma and Tech News,Daratumumab,myelofibrosis,Hematology News,autoimmune cytopenias,T-cell acute lymphoblastic leukemia,CD7 CAR-Tminimal residual disease,allogeneic CAR-T

A focused weekly roundup of hematology and cell-therapy developments, covering…

by LucidQuest

Onco_background

Oncology Today—January 26, 2026

January 26, 2026merck,breast cancer,BioNTech,BioPharma and Tech News,lung cancer,melanoma,antibody drug conjugate,pembrolizumab,Oncology Newshead and neck squamous cell carcinoma,FDA fast track

This week's Oncology update spans regulatory milestones, late-stage clinical…

by LucidQuest

Artificial_Intelligence

AI in Healthcare and Digital Health Video Recap —January 26, 2026

January 26, 2026Google,FDA,BioPharma and Tech News,Anthropic,OpenAI,Bristol Myers Squibb,AI in Healthcare and Digital Health,CMS,Claude for Healthcare,Medidata,GPTZeroMerge Labs BCI,Google Gemini Personal Intelligence

This biweekly video recap in AI in Healthcare and Digital Health covers…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: PAQ Therapeutics Series B for PT0511 pan-KRAS degrader

January 26, 2026Oncology,clinical trials,Regulatory,biopharma,KRAS,Lucid Diligence Brief,payer access,diligence,market landscape,targeted protein degradationinvestor brief

Lucid Diligence Brief: PAQ Therapeutics Series B for PT0511 pan-KRAS degrader…

by Timos Papagatsias

Artificial_Intelligence

AI in Healthcare and Digital Health Today—January 26, 2026

January 26, 2026Brainomix,Cancílico,Insilico Medicine,Citizen Health,BioPharma and Tech News,Remidio,Parkinson's Disease,ARPA-H,Boehringer Ingelheim,Glaucoma,Microsoft,axial spondyloarthritis,OpenAI,Gates Foundation,Bristol Myers Squibb,AI in Healthcare and Digital Health,Qure.ai,NeuraLightinterstitial lung disease,Teitur Trophics

This week's AI in Healthcare and Digital Health update covers advances…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: CORXEL $287m Series D1 for oral GLP-1 development

January 25, 2026clinical trials,Regulatory,obesity,GLP-1,biopharma,China,Lucid Diligence Brief,payer access,diligence,cardiometabolic,financingU.S. market

Lucid Diligence Brief: CORXEL $287m Series D1 for oral GLP-1 development…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled rare-disease therapeutics

January 24, 2026clinical trials,AI in healthcare,rare disease,biopharma,Lucid Diligence Brief,payer access,diligence,venture financing,HTA,commercializationportfolio strategy

Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled…

by Timos Papagatsias

Respiratory

Respiratory Video Recap—January 23, 2026

January 23, 2026cystic fibrosis,BioPharma and Tech News,air pollution,Boehringer Ingelheim,Idiopathic Pulmonary Fibrosis,Krystal Biotech,Respiratory News,severe asthma,Alpha-1 antitrypsin deficiency,KB407Epetraborole,Frevecitinib

This biweekly Respiratory Video Recap highlights key developments across…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.